NEW YORK (Reuters) – Drug makers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID–19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts…

Read More